Safety Syringes Market
Safety Syringes Market Size, Share & Industry Analysis, By Product Type (Retractable Safety Syringes, Non-Retractable Safety Syringes), By Mechanism (Manual, Automatic), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
The Safety Syringes Market is projected to grow at a CAGR of 8.3% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031. North America currently dominates the market, with key metrics indicating strong growth in healthcare infrastructure and stringent safety regulations. The market is experiencing significant expansion due to increasing awareness about needlestick injuries, growing prevalence of chronic diseases requiring injectable medications, and technological advancements in syringe design.
Safety Syringes Market Dynamics:
Market Trend: Rising adoption of prefilled safety syringes drives market growth
The safety syringe market is shifting significantly towards the usage of prefilled safety syringes. These new gadgets combine the advantages of safety systems with the ease and accuracy of prefilled drugs. Prefilled safety syringes have various benefits, including fewer pharmaceutical errors, enhanced dosage precision, and increased sterility. Healthcare practitioners are quickly recognising the benefits of these devices in reducing the risk of needlestick injuries and speeding up medication administration procedures. This trend is being driven by rising demand for self-administration of injectable medications, particularly in the treatment of chronic illnesses like diabetes and autoimmune disorders. As pharmaceutical companies continue to develop biologics and other injectable treatments, demand for prefilled safety syringes is likely to rise, propelling market growth in the years ahead.
Market Driver: Stringent regulations mandating the use of safety-engineered devices fuel market expansion
The safety syringes market is rapidly growing as a result of strict regulations requiring the use of safety-engineered devices in healthcare settings. Governments and regulatory bodies around the world have taken steps to reduce the number of needlestick injuries and related illnesses among healthcare professionals. For example, the United States Needlestick Safety and Prevention Act of 2000 greatly increased the use of safety syringes across the country. According to recent occupational safety data, adopting safety-engineered equipment reduced needlestick injuries among healthcare personnel by 38% over the last decade. Similar rules in Europe, such as the EU Directive 2010/32/EU, have accelerated regional market expansion. These legal mandates have not only raised demand for safety syringes, but have also spurred innovation in syringe design and safety systems, resulting in market growth.
Market Restraint: Higher costs associated with safety syringes compared to conventional syringes limit widespread adoption
Despite the generally favourable outlook, the safety syringes industry has problems due to greater costs when compared to traditional syringes. Safety syringes are often 2-3 times more expensive than normal syringes, posing a major financial burden, especially for healthcare facilities in resource-constrained countries. A recent cost-analysis research found that switching to safety syringes could raise annual syringe expenditures by up to 30% for a medium-sized institution. This cost disparity can be a barrier to widespread adoption, particularly in developing nations where healthcare budgets are constrained. Furthermore, the greater complexity of some safety syringe designs may necessitate additional training for healthcare staff, driving up overall implementation costs. These issues, when combined, stifle market growth, especially in price-sensitive countries and places with minimal healthcare resources.
Segment Overview:
Retractable safety syringes dominate the market, driven by superior safety features and ease of use:
The retractable safety syringes sector now dominates the safety syringes industry. This domination is due to the increased safety features provided by retractable syringes, which effectively reduce the danger of needlestick injuries by automatically withdrawing the needle into the syringe barrel after use. Retractable syringes offer more protection to healthcare staff and patients, along with the growing emphasis on occupational safety in healthcare settings.
According to recent industry study, retractable safety syringes will account for almost 60% of total safety syringe sales by 2023. This segment has grown steadily, with sales volume increasing by 7% every year. The pharmaceutical and medical device sectors have made substantial contributions to the segment's growth, with ongoing research and development efforts targeted at enhancing retraction mechanisms and overall usability.
A major medical equipment manufacturer reported a 15% increase in retractable safety syringe sales in 2023, citing increased demand from hospitals and vaccination programs. The COVID-19 pandemic has expedited the use of retractable safety syringes, with many healthcare facilities choosing these devices to ensure maximum safety during large-scale immunisation operations.
Regional Outlook:
North America leads the safety syringes market, driven by stringent regulations and advanced healthcare infrastructure:
North America currently controls the safety syringe industry. This leadership position is due in part to the region's tight regulatory framework, advanced healthcare infrastructure, and healthcare professionals' deep knowledge of needlestick injury prevention procedures.
The United States, in particular, has been at the forefront of safety syringe use, with the Needlestick Safety and Prevention Act serving as a main driver of industry expansion. The Act requires the use of safety-engineered devices in healthcare settings, resulting in widespread adoption throughout hospitals, clinics, and other medical facilities. According to recent market projections, North America will account for around 40% of worldwide safety syringe sales by 2023.
Canada has also emerged as a major competitor in the regional economy, thanks to its universal healthcare system, which prioritises worker safety and infection control. The Canadian Centre for Occupational Health and Safety has actively promoted the adoption of safety-engineered medical equipment, leading to greater market growth in the country.
The region's dominance is likely to remain throughout the projection period, aided by ongoing technological breakthroughs in syringe design and the rising prevalence of chronic conditions that require injectable drugs. The ageing population in North America, combined with rising demand for home healthcare services, is expected to increase the use of safety syringes in the future years.
Competitive Intelligence:
The safety syringes market is characterised by fierce competition among the major companies, with an emphasis on product innovation and strategic alliances. Leading organisations are investing much in R&D to create better safety systems and enhance the user experience. Market leaders have maintained their positions by combining extensive product portfolios, robust distribution networks, and sufficient clinical proof to demonstrate the efficacy of their inventions.
According to a recent industry survey, the top five organisations own more than 65% of the market. These organisations have been aggressively looking for mergers and acquisitions to broaden their product offerings and geographical reach. For example, in 2023, a big medical equipment business purchased a specialised safety syringe producer, gaining access to proprietary retraction technology and expanding its global market presence.
Collaboration with healthcare professionals and academic institutions has emerged as a critical approach for industry players seeking to boost innovation and clinical acceptance. Several firms have formed research partnerships to produce next-generation safety syringes, with a focus on enhancing simplicity of use and compatibility with a wide range of drugs.
In terms of financial performance, the market leaders have demonstrated consistent revenue growth, with average year-over-year increases of 6-8% in their safety syringe categories. This increase is mostly due to increased demand for safety-engineered equipment in both developed and emerging markets, as well as the global development of immunisation programs.
Analyst Opinion:
The safety syringes market is expected to expand substantially in the next years as a result of regulatory requirements, technological advancements, and increased awareness of needlestick injury prevention. The continued global focus on healthcare worker safety, particularly in light of the COVID-19 outbreak, is projected to be a significant driver of market growth.
One of the most intriguing subjects to follow is the incorporation of smart technologies into safety syringes. The development of connected syringes that include dose tracking and drug adherence monitoring has the potential to revolutionise injectable medicine administration and clinical treatment. As the Internet of Medical Things (IoMT) evolves, smart safety syringes have the potential to significantly improve treatment results and eliminate pharmaceutical mistakes.
Another area of research is the creation of eco-friendly safety syringes. With increased worries about medical waste and environmental sustainability, manufacturers are looking into biodegradable materials and designs that reduce environmental effect while maintaining safety. Companies that successfully create and commercialise environmentally friendly safety syringes will likely gain a considerable competitive advantage in the market.
Major Players:
-
Becton, Dickinson and Company
-
B. Braun Melsungen AG
-
Smiths Medical
-
Terumo Corporation
-
Retractable Technologies, Inc.
-
Sol-Millennium Medical, Inc.
-
UltiMed, Inc.
-
Medtronic plc
-
Nipro Corporation
-
Cardinal Health, Inc.
Key Developments:
-
May 2024: Becton, Dickinson, and Company introduces a new line of prefilled safety syringes with a better retraction mechanism and compatibility with a wide range of injectable drugs.
-
Terumo Corporation entered into a strategic agreement with a top pharmaceutical company in March 2024 to develop innovative safety syringes for biologics administration, with a focus on the increasing market for self-administered injectable medications.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Becton, Dickinson and Company
5.2. B. Braun Melsungen AG
5.3. Smiths Medical
5.4. Terumo Corporation
5.5. Retractable Technologies, Inc.
5.6. Sol-Millennium Medical, Inc.
5.7. UltiMed, Inc.
5.8. Medtronic plc
5.9. Nipro Corporation
5.10. Cardinal Health, Inc. (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Rising adoption of prefilled safety syringes drives market growth
6.1.2. Increasing focus on needlestick injury prevention in healthcare settings
6.1.3. Growing demand for self-administration devices for chronic diseases
6.2. Market Drivers
6.2.1. Stringent regulations mandating the use of safety-engineered devices fuel market expansion
6.2.2. Technological advancements in syringe design and safety mechanisms
6.2.3. Rising prevalence of chronic diseases requiring injectable medications
6.3. Market Restraints
6.3.1. Higher costs associated with safety syringes compared to conventional syringes limit widespread adoption
6.3.2. Challenges in adapting to new safety syringe designs in clinical practice
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Retractable Safety Syringes
7.1.1. Manual Retractable Safety Syringes
7.1.2. Automatic Retractable Safety Syringes
7.2. Non-Retractable Safety Syringes
7.2.1. Sliding Needle Cover Syringes
7.2.2. Hinged Needle Cover Syringes
8. BY MECHANISM (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Manual
8.2. Automatic
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.2. Clinics
9.3. Ambulatory Surgery Centers
9.4. Others
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
By Product Type:
-
Retractable Safety Syringes
-
Non-Retractable Safety Syringes
By Mechanism:
-
Manual
-
Automatic
By End User:
-
Hospitals
-
Clinics
-
Ambulatory Surgery Centers
-
Others
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511